Opendata, web and dolomites
H2020 projects about "leukaemia"
The page lists 29 projects related to the topic "leukaemia".
| # | |||
|---|---|---|---|
| 1 | HAT-MOZ-sphere | Identification of genes and pathways regulated by the HAT activity of MOZ | 2015 |
| 2 | COMAL | COMAL:COhesin Mutations in Acute Leukemia: from modeling and mechanisms to novel therapeutics | 2015 |
| 3 | Phd | Deciphering PI3K biology in health and disease | 2015 |
| 4 | StemNicheOnWaveCrest | New therapies for myeloproliferative diseases based on multi-stage and -system analyses of the haematopoietic stem-cell niche | 2015 |
| 5 | AML-VACCiN | Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia | 2016 |
| 6 | TROJANANOHORSE | Hybrid immune-eluding nanocrystals as smart and active theranostic weapons against cancer | 2016 |
| 7 | CIRCLE | Investigation of the role of CYLD in Chronic Lymphocytic Leukaemia | 2016 |
| 8 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 9 | Autonomous CLL-BCRs | Role of autonomous B cell receptor signalling and external antigen in the pathogenesis of chronic lymphocytic leukaemia (CLL) | 2016 |
| 10 | DNAmethAML | Investigation of aberrant DNA methylation in malignant haematopoiesis | 2018 |
| 11 | DrugComb | Informatics approaches for the rational selection of personalized cancer drug combinations | 2017 |
| 12 | ChAMPioN | Game-changing Precision Medicine for Curing All Myeloproliferative Neoplasms | 2018 |
| 13 | ITHACA | Immuno-targeting of human AML quiescent cells by a novel phage display approach. | 2018 |
| 14 | CENTR-ALL | Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL) | 2019 |
| 15 | CRYOSTEM | Solvent free Cryopreservation of Hematopoietic Stem Cells | 2018 |
| 16 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 17 | ProMeta | Non-histone protein acetylation targets of KAT2A in AML | 2018 |
| 18 | Nano4 | Colorimetric Precision Nanodiagnostics made Fast and Affordable | 2018 |
| 19 | ExitAplasia | Reg-X310: new disruptive medicine for faster exit from aplasia afetr agressive chemotherapy of hematologic malignancies | 2018 |
| 20 | ONCORED | An unrivalled medical device based on red- light photo biomodulation to prevent, improve and remove oral mucositis and dermatitis chemo radio induced as a side effect of cancer treatment | 2018 |
| 21 | SeroStrat | The first blood test for the early detection and prognosis of Acute Myeloid Leukaemia | 2018 |
| 22 | PML-THERAPY | HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY | 2019 |
| 23 | MechanoIMM | Mechanical Immunoengineering for Enhanced T-cell Immunotherapy | 2018 |
| 24 | CLOSER | Childhood Leukemia: Overcoming distance between South America and Europe Regions | 2019 |
| 25 | ImmuNiche | Identifying spatial determinants of immune cell fate commitment | 2019 |
| 26 | SyLeNCe | Synapses between Leukaemia and its Neighbouring Cells | 2020 |
| 27 | IDEAL | Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia | 2020 |
| 28 | QUALITOP | Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management | 2020 |
| 29 | CATKERB | Total Syntheses of Catharanthine and Keramaphidin B by an Iridium-Catalyzed Reductive Cyclization Cascade | 2020 |